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OBJECTIVES The purpose of this study was to investigate whether pericardial fluid from patients with
unstable angina (UA) would modulate vascular endothelial cell survival.
BACKGROUND Apoptosis of vascular endothelial cells promotes the coagulation process, playing an important
role in the formation of coronary arterial thrombi. However, little is known about the
mechanisms of vascular endothelial cell death in acute coronary syndrome. We hypothesized
that factors inducing apoptosis are produced by the ischemic heart and accumulated in high
concentrations in pericardial fluid.
METHODS Pericardial fluid was obtained during coronary artery bypass surgery from patients with UA
(group A, n 5 8) and those with stable angina (group B, n 5 23). A survival assay of F2 cells
from a mouse vascular endothelial cell line was performed in the presence of 10% pericardial
fluid from each patient.
RESULTS Pericardial fluid levels of vascular endothelial growth factor were significantly higher in group
A than in group B, indicating that group A had more ischemic insults than group B.
Pericardial fluid from group A, but not from group B, markedly induced F2 cell death (cell
survival relative to fetal bovine serum; group A: 33 6 26% vs. group B: 91 6 22%, p , 0.01).
Cell death was associated with internucleosomal DNA fragmentation, a hallmark of
apoptosis. Fractionation of pericardial fluid using a Centricon C-100 demonstrated that
apoptosis-inducible activities exist in the Centricon C-100 retentates but not in the filtrates.
CONCLUSIONS Factors that induce vascular endothelial cell apoptosis are secreted into the pericardial space
from the hearts of patients with UA. These factors are large complexes or unknown new
proteins larger than 100 kDa. (J Am Coll Cardiol 2000;35:1785–90) © 2000 by the
American College of Cardiology
Fissuring or rupture of atherosclerotic plaque and subse-
quent formation of mural or occlusive thrombi in coronary
arteries are fundamental to the development of the acute
coronary syndrome (ACS), as has been shown in patholog-
ical studies on patients who died suddenly or shortly after an
episode of UA or acute myocardial infarction (1–3). Detec-
tion of endothelial cells in blood from patients with acute
coronary heart disease suggests substantial endothelial cell
death in these patients (4). Because endothelial cells play a
pivotal role in preventing the initiation and propagation of
the coagulation process, death of these cells triggers coag-
ulation by exposure of the subendothelial matrix or tissue
factor expressed on extravascular cells. In addition, Bombeli
et al. (5) demonstrated that apoptotic vascular endothelial
cells themselves become procoagulant. Thus, it is likely that
endothelial cell death plays an important causal role in the
formation of coronary arterial thrombi in patients with
ACS.
Apoptosis is an active process of cell death, morpholog-
ically and biochemically different from necrosis, and it
occurs under physiological and pathological conditions. In
addition to vasculogenesis, apoptosis of endothelial cells is
considered to contribute to vascular pathology. Endothelial
cell apoptosis in culture is caused by a number of stimuli,
including tumor necrosis factor-alpha (6), lipopolysaccha-
rides combined with heat shock (7) or ionizing radiation (8),
high glucose concentration (9) and low concentrations of
hydrogen peroxide (10). However, it is unknown whether
endothelial cell death in patients with ACS is attributable to
apoptosis.
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Substances produced by the heart are secreted into the
pericardial space and also into the systemic circulation. These
substances are accumulated in the pericardial fluid and present
at high concentrations. For example, in patients with heart
failure, levels of B-type natriuretic peptide are much higher in
the pericardial fluid than in plasma (11). These findings
prompted us to investigate whether factors inducing endothe-
lial cell death may be produced by the heart and accumulated
at high concentrations in pericardial fluid. Thus, we investi-
gated whether pericardial fluid obtained during coronary artery
bypass surgery would affect endothelial cell survival.
METHODS
Patient profile. All of the 31 patients in this study under-
went coronary artery bypass surgery because of double-vessel
(n 5 8), triple-vessel (n 5 12) or left main trunk disease
(n 5 11). The mean age of the patients (21 men and 10
women) was 68 6 10 years. The patients were divided into
two groups. Group A consisted of eight patients with UA.
Group B consisted of 23 patients with stable angina. Of
eight group A patients, six had class III UA according to
Braunwald’s classification (12), and the remaining two had
class II UA. All patients gave their written, informed
consent. The study protocol was approved by the ethical
committee on human research at Kyoto University.
Sampling of pericardial fluid. Immediately after incision
of the pericardium, undiluted pericardial fluid was obtained
and heparinized. The amount of non-hemorrhagic pericar-
dial fluid obtained was 3 6 2 ml in group A and 4 6 2 ml
in group B. The samples were collected in sterile tubes and
immediately placed on ice. After clarification of cellular
components by centrifugation at 3,000 g for 10 min at 4°C,
these samples were rapidly frozen in liquid nitrogen and
stored at 280°C until use.
Measurement of vascular endothelial growth factor
(VEGF). Concentrations of VEGF in pericardial fluid
were measured by an enzyme-linked immunosorbent assay
as described previously (13). In brief, this assay uses a
sandwich method of detection comprising a plate precoated
with a monoclonal antibody specific for VEGF. After
addition of the sample, an enzyme-linked polyclonal anti-
body was added. Color development was achieved by the
addition of a substrate solution; the degree of color devel-
opment correlated with the amount of VEGF. The limit of
VEGF detection in this assay was 1 pg/ml. The difference in
values between the two measurements was within 10%.
Cell culture. The mouse endothelial cell line (F2 cells) was
obtained from a murine vascular endothelial cell line (14)
and kept in media consisting of Dulbecco’s modified Eagle’s
medium plus 19.6 mM NaHCO3 (pH 7.1 to pH 7.2),
penicillin, streptomycin, and 10% (vol/vol) fetal bovine
serum (FBS) (all from GIBCO BRL, Gaithersburg, Mary-
land) at 37°C, 5% CO2.
Cell survival assay. F2 cells were plated in triplicate in a
96-well microplate with 5 3 103 cells/well with the plating
medium and maintained at 5% CO2 and 37°C for 24 h. The
cells were then washed twice with the above medium
containing 0.1% serum, followed by the addition of 10%
pericardial fluid from each patient to the well. Forty-eight
hours later, the cells were stained with 3-(4,5-dimethyl
thiaziazol-2-yl)-2,5-diphenyl tetrazolium bromide (Sigma,
St. Louis, Missouri), and viable cells were counted by
measuring the optic density. The optic density of the well
incubated with 10% fetal bovine serum was set to 100% in
each experiment. In all experiments, we used identical
lots of FBS. All of the experiments were performed in
triplicate for each patient sample and repeated at least
three times.
DNA fragmentation on agarose gels. F2 cells were plated
on 10 cm plates with 5 3 105 cells/plate and maintained at
5% CO2 and 37°C for 24 h. The cells were then washed
twice with the above medium containing 0.1% serum,
followed by the addition of 10% pericardial fluid from each
patient to the well. Forty-eight hours later, the cells were
harvested by scraping them into the media. After centrifu-
gation at 500 g for 5 min at 4°C, the cells were lysed in a
lysis buffer and subjected to a nucleosomal ladder assay using
a commercial kit (Takara Biomedicals, Kyoto, Japan) ac-
cording to the manufacturer’s recommendations. The pres-
ence of characteristic 180- to 200-bp multiple oligonucleo-
somal fragmentation was examined on 2% agarose gels
stained with SYBR™Green I (Takara Biomedicals).
Protein fractionation of pericardial fluid with Centricon
C-100. To prepare the Centricon C-100 retentates and
filtrates, 1 ml of pericardial fluid was centrifuged in a
Centricon C-100 concentrator at 500 g for 60 min. The
retentate was washed with N-2-hydroxyethylpiperazine-
N9-2-ethanesulfonic acid buffer plus 100mM KCl and
centrifuged again. Then, the retentate was recovered by
reverse spinning the concentrator for 3 min at 500 g. The
first filtrate and the final retentate were used for the F2 cell
survival assay.
Statistical analysis. All values were expressed as mean 6
SD. The differences between the groups were analyzed with
the Mann-Whitney U test. Proportional data concerning
the ladder formation of DNA were analyzed using the
chi-square test with Yates’ correction. A p value ,0.05 was
taken to indicate significance.
Abbreviations and Acronyms
ACS 5 acute coronary syndrome
FBS 5 fetal bovine serum
UA 5 unstable angina
VEGF 5 vascular endothelial growth factor
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RESULTS
Patient profile. Table 1 shows the clinical characteristics of
group A and B patients. There were no significant differ-
ences in age, gender distribution, extent of coronary artery
stenosis and risk factors between group A and B patients.
Six patients in group A and 16 in group B had old
myocardial infarction, but none had acute or recent myo-
cardial infarction. Echocardiographic data demonstrated
that there were no differences in the left ventricular end-
diastolic and end-systolic diameters and ejection fraction
between these two groups. There were no differences
between these two groups in pre-operative medications such
as calcium antagonists, angiotensin-converting enzyme in-
hibitors, beta-blockers and intravenous heparin. However,
group A patients received intravenous heparin more fre-
quently than group B patients.
Pericardial fluid level of VEGF. We measured pericardial
fluid levels of VEGF using an enzyme-linked immunosor-
bent assay. In a previous report, we demonstrated that
pericardial fluid levels of VEGF increased only in patients
with severe rest angina within two days before emergent
coronary artery graft surgery, not in those with stable angina
(13). These findings suggest that the increase in pericardial
fluid levels of VEGF serves as a marker of recent ischemic
insults. Pericardial fluid levels of VEGF were significantly
higher in group A than in group B, consistent with the
former having had more recent ischemic insults than the
latter.
Effects of pericardial fluid on endothelial cell survival
and apoptosis. To investigate whether pericardial fluid
from patients with UA affects the survival of endothelial
cells, we stimulated F2 cells with 10% pericardial fluid from
each patient. Forty-eight hours later, we counted the viable
cell number by measuring the optic density in the well. As
shown in Figure 1, the cell viability in group A (UA) relative
to 10% FBS was 33 6 26%, which was much lower (p ,
0.001) than that in group B (stable angina, 91 6 22%).
Incubation of endothelial cells in serum-free media resulted
in mild loss of these cells (the cell viability was 87% relative
to 10% FBS control). To investigate whether the decrease in
viable F2 cells after stimulation with pericardial fluid from
group A is attributable to apoptosis of these cells, we
evaluated F2 cells for the presence of internucleosomal
cleavage by monitoring for DNA laddering, a hallmark of
apoptosis. Figure 2 illustrates representative DNA frag-
ments equivalent in size to the mononucleosomes and
oligonucleosomes in F2 cells 48 h after incubation with
pericardial fluid from UA (left lane) but not in cells
incubated with pericardial fluid from stable angina (right
lane). The DNA fragmentation of F2 cells was detected in
Table 1. Comparison of Patients’ Characteristics Between Group A (UA) and Group B (Stable
Angina)
Group A
(n 5 8)
Group B
(n 5 23)
p
Value
Age (yr) 70.9 6 8.9 66.4 6 10.2 N.S.
Male 5/8 (62.5%) 16/23 (69.6%) N.S.
History of myocardial infarction 6/8 (75.0%) 16/23 (69.6%) N.S.
Left main trunk disease 2/8 (25.0%) 9/23 (39.1%) N.S.
3-vessel disease 5/8 (62.5%) 7/23 (30.4%) N.S.
Hypertension 4/8 (50.0%) 11/23 (47.8%) N.S.
Diabetes mellitus 2/8 (25.0%) 9/23 (39.1%) N.S.
Cigarette smoking 3/8 (37.5%) 6/23 (26.1%) N.S.
Serum total choresterol (mg/dl) 178.3 6 23.9 181.6 6 50.8 N.S.
LVDd (mm) 52.4 6 11.4 51.2 6 7.2 N.S.
LVSd (mm) 39.1 6 12.6 35.7 6 10.7 N.S.
LVEF (%) 51.8 6 16.5 53.0 6 15.6 N.S.
VEGF in pericardial fluid (pg/ml) 84.1 6 23.3 29.8 6 17.6 p , 0.001
TNF-alpha in pericardial fluid (pg/ml) , 15.6 , 15.6 N.S.
Intravenous heparin 6/8 (75.0%) 5/23 (21.7%) p , 0.01
Ca antagonists 4/8 (50.0%) 12/23 (52.2%) N.S.
ACE inhibitors 1/8 (12.5%) 4/23 (17.4%) N.S.
Beta-blockers 1/8 (12.5%) 2/23 (8.7%) N.S.
Nitrates 7/8 (87.5%) 48/23 (78.3%) N.S.
Anti-platelet agents 3/8 (37.5%) 8/23 (34.8%) N.S.
Data are presented as number (%) of patients or mean value 6 SD. ACE 5 angiotensin coverting enzyme; LVDd 5 left
ventricular diastolic demension; LVEF 5 left ventricular ejection fraction; LVSd 5 left ventricular systolic dimension; TNF 5
tumor necrosis factor; VEGF 5 vascular endothelial growth factor.
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7 of 8 group A patients but in only 1 of 23 group B patients
(p , 0.01). The cells stimulated with pericardial fluid from
patients with UA displayed the small condensed nuclei, cell
shrinkage and nuclear fragmentation that are consistent
with the morphologic features of apoptosis (Fig. 3B). Thus,
F2 cell death caused by pericardial fluid was associated with
the presence of DNA fragmentation and the morphologic
features of apoptosis, indicating that pericardial fluid from
group A patients induced endothelial cell death by apopto-
sis.
Characterization of apoptosis-inducible factors. We be-
gan to characterize apoptosis-inducible factor(s) in pericar-
dial fluid from patients with UA. One of the most impor-
tant factors involved in apoptosis in many cell types is tumor
necrosis factor-alpha. Therefore, we measured pericardial
fluid levels of tumor necrosis factor-alpha by an enzyme-
linked immunosorbent assay. However, these levels were
less than the level detectable by this assay and did not differ
between group A and group B patients (Table 1). To
examine the role of the Fas-Fas ligand system in endothelial
cell apoptosis by pericardial fluid, we administered a neu-
tralizing antibody against Fas ligand. However, as shown in
Figure 4, it failed to inhibit the cell death–inducing activi-
ties of pericardial fluid from group A patients. Before the
addition to the well, pericardial fluid from UA was heated to
55°C for 30 min or freezed and thawed twice. Each
procedure eliminated the cell death–inducing activity of the
pericardial fluid, suggesting the lability of the factor(s). To
investigate whether apoptosis-inducible factor(s) in pericar-
dial fluid exist in fractions of molecular weight greater or
less than 100 kDa, pericardial fluid from group A and group
B patients was fractioned with the Centricon C-100, and
each retentate and filtrate was subjected to the F2 cell
survival assay. As shown in Figure 5A, the Centricon C-100
retentates contain substances with molecular weights more
than 100 kDa. However, such high molecular substances do
Figure 1. Pericardial fluid from patients with UA induces loss of
F2 cells. F2 cells were plated in 96 well plates and maintained for
48 h in the presence of 10% pericardial fluid obtained during
coronary artery bypass surgery. Cell viability was assayed using
3-(4,5-dimethyl thiaziazol-2-yl)-2,5-diphenyl tetrazolium bro-
mide as described under “Methods.” In each experiment, the
viability of the well incubated with 10% FBS was set to 100%. All
of the experiments were performed in triplicate for each patient
sample and repeated at least three times. Results are the mean 6
SD of each patient group.
Figure 2. Fragmentation of genomic DNA in F2 cells incubated
with pericardial fluid from a patient with UA. Genomic DNA was
isolated from F2 cells maintained for 48 h in the presence of 10%
pericardial fluid from a patient with UA (left lane) or stable angina
(right lane) and loaded on a 2% agarose gel. The ladder assays were
performed in all patients, and the data presented are representative.
Figure 3. Induction of apoptosis in F2 cells by pericardial fluid
from a patient with UA. A representative photograph of F2 cells
incubated with pericardial fluid from patients with stable angina
(A) and UA (B). These cells were stained with hematoxylin.
Arrow heads show cells with evidence of apoptosis, including
chromatin condensation.
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not exist in the filtrate. As shown in Figure 3, when the
Centricon C-100 filtrates were added to the well, the
percentage of optic density did not differ between the two
groups (78 6 12% in group A vs. 81 6 16% in group B,
NS). By contrast, with the Centricon C-100 retentates, the
percentage of optic density in group A (19 6 27%) was
much lower (p , 0.001) than that in group B (86 6 25%).
These findings suggest that apoptosis-inducible factor(s) in
pericardial fluid from patients with UA reside(s) in the
Centricon C-100 retentates.
DISCUSSION
Vascular endothelial cell death in UA. Unstable angina is
a disease status of high risk for subsequent coronary arterial
thrombosis. Much evidence suggests that endothelial cell
death is involved in the pathophysiology of ACS (1–5).
Because vascular endothelial cells provide potent anti-
coagulant properties, death of these cells promotes the
coagulation process, leading to coronary arterial thrombosis.
Despite the pathophysiological importance of endothelial
cell death, little is known about its regulators in ACS. This
study demonstrates that pericardial fluid from patients with
UA, but not from those with stable angina, induced endo-
thelial cell death. This was associated with internucleosomal
DNA fragmentation, suggesting that cell death is mainly
attributable to apoptosis. Considering the fact that the
occurrence of apoptosis is determined by the balance be-
tween inducers and inhibitors of apoptosis, we cannot rule
out the possibility that the pericardial fluid from UA
patients lacks factors indispensable for cell survival. Even if
this is the case, a marked decrease in F2 cell survival in this
fluid suggests that it contains potent apoptosis-inducible
factor(s).
Myocardial ischemia and VEGF. Ischemic myocardium
produces protective factors against apoptosis (13,15). One
of them is VEGF (16). We previously reported that severe
myocardial ischemia causes release of this factor into the
pericardial space (13). Compatible with that report, this
study demonstrates that pericardial fluid levels of VEGF are
elevated in patients with UA compared with those with
stable angina. Despite the high levels of this protective
factor in pericardial fluid from UA patients, the fluid
induced apoptosis of endothelial cells. It should be further
clarified whether endothelial cell apoptosis occurs via dis-
tinct pathways or the levels of VEGF are insufficient to
Figure 4. The effect of a neutralizing antibody against Fas ligand
on the cell death–inducing activity of pericardial fluid from
patients with UA. F2 cells were incubated with 10% pericardial
fluid from patients with UA in the presence or absence of a
neutralizing antibody against Fas ligand (1 mg/ml). Cell survival
assays were performed as described in the legend for Figure 1. In
each experiment, the viability of the well incubated with 10% fetal
bovine serum was set to 100%. All of the experiments were
performed in triplicate for each patient sample and repeated at least
three times. Results are the mean 6 SD of each group.
Figure 5. Cell death–inducing activities exist in the Centricon
C-100 retentates. Pericardial fluid was fractionated with Centricon
C-100 as described under “Methods.” A) A representative photo-
graph showing a retentate (R) and a filtrate (F) electrophoresced by
an SDS-polyacrylamide (2% to 15%) gradient gel and stained with
Coomassie Brilliant Blue. MW 5 molecular weight. B) In each
retentate and filtrate, F2 cell survival assays were performed as
described in the legend for Figure 1. In each experiment, the
viability of the well incubated with 10% FBS was set to 100%. All
of the experiments were performed in triplicate for each patient
sample and repeated at least three times. Results are the mean 6
SD of each patient group.
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produce its protective effects. Nevertheless, our data clearly
indicate that the hearts of group A patients had been
subjected to more severe ischemia than those of group B.
Apoptosis in vascular endothelial cells. A number of
factors can induce apoptosis in endothelial cells. One
important factor involved in the apoptosis of many cell types
is tumor necrosis factor-alpha. However, pericardial fluid
levels of tumor necrosis factor-alpha were almost undetect-
able using an enzyme-linked immunosorbent assay. Other
factors that have been reported to induce endothelial cell
apoptosis include oxidized low density lipoproteins (17,18),
sphingolipids (19,20) and proinflammatory cytokines other
than tumor necrosis factor-alpha, such as interleukin-1beta.
We demonstrated here that apoptosis-inducible activities
exist in the Centricon C-100 retentates but not in the
filtrates. These findings suggest that apoptosis-inducible
factors are greater than 100 kDa in molecular weight, or
that factors ,100 kDa form complexes that are retained in
the Centricon C-100. Because most factors reported to
induce endothelial cell apoptosis are ,100 kDa, it is
probable that large complexes consist of single or multiple
substances or that unknown new proteins .100 kDa are
responsible for the apoptosis-inducible activities in pericar-
dial fluid.
Study limitations. We should also consider the possibility
that pre-existing molecules in pericardial fluid are modified
by ischemic insults to gain apoptosis-inducible properties.
Patients with UA received intravenous heparin more fre-
quently than those with stable angina. However, the
apoptosis-inducible factors contained in pericardial fluid
from these patients are high molecular substances. Although
we cannot totally rule out the possibility that heparin
modulated the death-inducible activity of other substances,
heparin can provide the growth of endothelial cells. There-
fore, it is highly unlikely that heparin is responsible for the
endothelial cell apoptosis observed in this study. Although
the heart is a main source of pericardial fluid, cardiac tissue
consists of a number of cell types. Therefore, for the
identification of apoptosis-inducible factors produced by
the heart, it should be clarified which cell type is
responsible for their production. In any event, identifying
factors that induce endothelial cell apoptosis in patients
with UA will provide novel insights into the mechanisms
that mediate plaque rupture of atherosclerotic coronary
arteries.
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